What is LOPJLB’s current signal on GANX?

LOPJLB’s latest quantitative signal on Gain Therapeutics, Inc. (GANX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is GANX in?

Gain Therapeutics, Inc. (GANX) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Gain Therapeutics, Inc. based / listed?

Gain Therapeutics, Inc. is based in US, listed on NASDAQ.

Gain Therapeutics, Inc. (GANX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$1.62-2.99%Close

SELLCRISIS · day 8

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $69M
Beta: 0.19
P/E (TTM): -3.34

Short % float: 6.93%
Days to cover: 8.9
SI change: +3.3%

1W: -5.81%
1M: -5.81%

vs SPY 1W: -7.37%
vs SPY 1M: -7.58%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Gain Therapeutics, Inc. is a biotechnology firm specializing in the creation of advanced treatments for conditions originating from improperly folded proteins. The company primarily directs its efforts towards rare genetic disorders and neurological ailments. It employs its…

Employees: 21
Headquarters: US
Founded: 2021
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 42.7M
Float: 97.6%

gaintherapeutics.com ↗

Key executives

Gene Mack — President, Chief Executive Officer & Director

Gianluca Fuggetta — Senior Vice President of Finance & Principal Financial Officer

Khalid Islam — Chairman & Founder

SEC filings

EDGAR · CIK 18194110 · GANX

Analyst consensus

Buy

Bullish787.5%

Neutral112.5%

Bearish00.0%

L $5.00Avg $5.00H $5.00

Target$5.00+208.64%

Last$1.62

Key stats

Prediction markets

Company news